A multicentre randomized controlled study of Dingxuan Decoction combined with computer traction in the treatment of vertebral artery type cervical spondylopathy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2100004244

Enrollment

Unknown

Registered

2021-01-10

Start date

2021-01-30

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertebral artery type cervical spondylosis

Interventions

Treatment group:Oral Dingxuan soup combined with computer traction

control group:The computer drawing

Eligibility

Sex/Gender

All

Age

25 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patient who meet the diagnostic criteria of cervical spondylosis; 2. Aged 25-55 years; 3. Course of disease <= 5 years; 4. If the patient has received other conservative treatment, he/she must go through a washout period of more than 5 days; 5. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Other types of cervical spondylosis; 2. Cervical vertebra with dislocation, fracture, tuberculosis, acute cervical disc herniation, infection and tumor; 3. Vertigo diseases caused by aural, cerebral, traumatic, ophthalmic, neurofunctional, and intracranial tumors; 4. Subclavian artery steal syndrome; 5. Patients with severe heart, liver, brain, kidney complications and other serious diseases; 6. Pregnant women and mental patients. 7. Allergic to Traditional Chinese medicine.

Design outcomes

Primary

Measure	Time frame
Quality of Life Scale SF-12;TCD;ESCV;	—

Countries

China

Contacts

Public ContactLi Jinyu

Dongzhimen Hospital of Beijing University of Chinese Medicine

leery_5566@163.com+86 13810832711

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026